THROMBOTIC THROMBOCYTOPENIC PURPURA
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough study could eliminate need for Blood-Cleansing procedure in rare blood disease
Disease control CompletedThis study tested whether a combination of two medications could effectively treat a rare, serious blood disorder called immune-mediated thrombotic thrombocytopenic purpura (iTTP) without using the standard first treatment of therapeutic plasma exchange. The trial involved 51 adu…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New treatment tested to stop rare blood disorder from coming back
Disease control CompletedThis study tested whether a drug called caplacizumab could prevent acquired thrombotic thrombocytopenic purpura (aTTP), a rare and serious blood clotting disorder, from coming back in Japanese patients. The trial involved 21 adults who were already receiving standard treatment fo…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA
Phase: PHASE2, PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC